Cochlear Limited (ASX:COH)
136.10
-1.66 (-1.20%)
Aug 28, 2026, 4:10 PM AEST
Cochlear Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 2,348 | 2,343 | 2,236 | 1,936 | 1,648 | |
Revenue Growth | 0.19% | 4.81% | 15.47% | 17.46% | 10.06% |
Cost of Revenue | 688 | 615.2 | 562.1 | 488 | 411 |
Gross Profit | 1,660 | 1,728 | 1,674 | 1,448 | 1,237 |
Selling, General & Admin | 928.2 | 939.9 | 897.6 | 810.4 | 657.7 |
Research & Development | 323.2 | 281.2 | 277 | 244.9 | 210.7 |
Other Operating Expenses | -13.3 | -16.1 | -10.7 | -13.5 | -12 |
Operating Expenses | 1,238 | 1,205 | 1,164 | 1,042 | 856.4 |
Operating Income | 421.5 | 522.9 | 509.6 | 406.3 | 380.9 |
Interest Expense | -13.2 | -11 | -9.2 | -9.4 | -8.6 |
Interest & Investment Income | 10.2 | 11.7 | 19 | 16.5 | 2.4 |
Earnings From Equity Investments | - | - | -0.6 | -0.2 | - |
Currency Exchange Gain (Loss) | 11.1 | -1.6 | -4.8 | -10.2 | 0.1 |
EBT Excluding Unusual Items | 429.6 | 522 | 514 | 403 | 374.8 |
Merger & Restructuring Charges | - | - | -28.2 | - | - |
Gain (Loss) on Sale of Investments | -121.4 | -3.5 | -1.3 | -6.4 | 17.3 |
Other Unusual Items | -94.3 | - | 0.3 | - | 1.7 |
Pretax Income | 213.9 | 518.5 | 484.8 | 396.6 | 393.8 |
Income Tax Expense | 66.6 | 129.6 | 128 | 96 | 104.7 |
Net Income | 147.3 | 388.9 | 356.8 | 300.6 | 289.1 |
Net Income to Common | 147.3 | 388.9 | 356.8 | 300.6 | 289.1 |
Net Income Growth | -62.12% | 9.00% | 18.70% | 3.98% | -10.72% |
Shares Outstanding (Basic) | 65 | 65 | 66 | 66 | 66 |
Shares Outstanding (Diluted) | 66 | 66 | 66 | 66 | 66 |
Shares Change | -0.11% | -0.17% | -0.27% | 0.19% | 0.06% |
EPS (Basic) | 2.25 | 5.94 | 5.44 | 4.57 | 4.40 |
EPS (Diluted) | 2.25 | 5.93 | 5.43 | 4.56 | 4.40 |
EPS Growth | -62.08% | 9.17% | 19.05% | 3.76% | -10.77% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 306.9 | 175.2 | 326.4 | 312.4 | 332 |
Free Cash Flow Per Share | 4.68 | 2.67 | 4.97 | 4.74 | 5.05 |
Dividend Per Share | 3.450 | 4.300 | 4.100 | 3.300 | 3.000 |
Dividend Growth | -19.77% | 4.88% | 24.24% | 10.00% | 17.65% |
Gross Margin | 70.69% | 73.74% | 74.86% | 74.80% | 75.06% |
Operating Margin | 17.95% | 22.32% | 22.80% | 20.98% | 23.11% |
Profit Margin | 6.27% | 16.60% | 15.96% | 15.53% | 17.54% |
Free Cash Flow Margin | 13.07% | 7.48% | 14.60% | 16.14% | 20.14% |
EBITDA | 479.9 | 573.7 | 554.4 | 447.9 | 417.5 |
EBITDA Margin | 20.44% | 24.48% | 24.80% | 23.13% | 25.33% |
D&A For EBITDA | 58.4 | 50.8 | 44.8 | 41.6 | 36.6 |
EBIT | 421.5 | 522.9 | 509.6 | 406.3 | 380.9 |
EBIT Margin | 17.95% | 22.32% | 22.80% | 20.98% | 23.11% |
Effective Tax Rate | 31.14% | 25.00% | 26.40% | 24.21% | 26.59% |